Recent advances in inducible cyclooxygenase (COX-2) inhibition

X de Leval, J Delarge, F Somers, P de Tullio, Y Henrotin, B Pirotte, J M Dogné

Résultats de recherche: Contribution à un journal/une revueArticleRevue par des pairs


Cyclooxygenase is the key enzyme in the biosynthesis of prostanoids, biologically active substances that are involved in several physiological processes but also in pathological conditions such as inflammation. Since ten years now, it is well known that this enzyme exists under two forms: a constitutive (COX-1) and an inducible form (COX-2). Both enzymes are sensitive to inhibition by conventional nonsteroidal anti-inflammatory drugs (NSAIDs). Observations that COX-1, involved in several homeostatic processes, played a housekeeping role while COX-2 expression was associated with inflammation and other pathologies such as cancer proliferation have led to the development of COX-2 selective inhibitors in order to reduce the classical side-effects, of which gastric irritation is the most common, associated with the use of conventional NSAIDs.
langue originaleAnglais
Pages (de - à)1041-62
Nombre de pages22
journalCurrent Medicinal Chemistry
Numéro de publication10
Etat de la publicationPublié - oct. 2000

Empreinte digitale

Examiner les sujets de recherche de « Recent advances in inducible cyclooxygenase (COX-2) inhibition ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation